Literature DB >> 11404718

[Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations. Current data and analysis of recent literature].

J P Castel1, G Kantor.   

Abstract

BACKGROUND AND
PURPOSE: Microsurgical exclusion of a cerebral arteriovenous malformation (AVM) can compare favorably with radiosurgery. We sought to assess its rate of morbidity-mortality as it is presently reported in the literature, and to discuss some of its current and worthwhile indications.
METHODS: Through Medline and additional searches by hand, we retrieved studies reporting the clinical and angiographic results after microsurgical excision of an AVM published between january 1990 and december 2000.
RESULTS: a) Postoperative mortality was 3.3% (68/2 452 patients from 25 studies). Permanent postoperative morbidity was 8.6%. Morbidity was never absent varying from 1.5% to 18,7%. The morbidity-mortality rate increased with an increasing Spetzler-Martin's grade, and was related to the location of the AVM. A 4.6% morbidity (from 1.5% to 9.7%) and a zero mortality were reported after microsurgical removal of small lesions of less than 3 cm in diameter. b) Postoperative angiography confirmed a total excision of the AVM in 97% of the cases (1 050/1 076 patients over 11 series), varying from 91% to 100%. c) Permanent morbidity related to pre-surgical embolization varied from 4% to 8.9%. Results from multiple or combined treatment including microsurgery could not be summed up.
CONCLUSIONS: A complete and definitive microsurgical excision of an AVM can be achieved with a high success rate and a low morbidity-mortality rate, according to sound indications and to the neurosurgeon's personal experience. The choice for a best treatment of an AVM is no longer limited to microsurgery; it is a team decision where the neurosurgeon plays a determining role.

Entities:  

Mesh:

Year:  2001        PMID: 11404718

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  10 in total

1.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 2.  Treatment of arteriovenous malformations of the brain.

Authors:  Andreas Hartmann; Henning Mast; Jae H Choi; Christian Stapf; Jay P Mohr
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

3.  Acute management of brain arteriovenous malformations.

Authors:  Andreas Hartmann; J P Mohr
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

4.  Leksell gamma knife radiosurgery for cerebral arteriovenous malformations in pediatric patients.

Authors:  Antonio Nicolato; Roberto Foroni; Andrea Seghedoni; Valentina Martines; Francesco Lupidi; Piergiuseppe Zampieri; Marco F Sandri; Umberto Ricci; Carlo Mazza; Alberto Beltramello; Massimo Gerosa; Albino Bricolo
Journal:  Childs Nerv Syst       Date:  2005-01-15       Impact factor: 1.475

5.  Accuracy of susceptibility-weighted imaging for the detection of arteriovenous shunting in vascular malformations of the brain.

Authors:  Bharathi D Jagadeesan; Josser E Delgado Almandoz; Christopher J Moran; Tammie L S Benzinger
Journal:  Stroke       Date:  2010-11-18       Impact factor: 7.914

6.  The ARUBA trial: current status, future hopes.

Authors:  J P Mohr; Alan J Moskowitz; Christian Stapf; Andreas Hartmann; Karen Lord; Steven M Marshall; Henning Mast; Ellen Moquete; Claudia Scala Moy; Michael Parides; John Pile-Spellman; Rustam Al-Shahi Salman; Alan Weinberg; William L Young; Alejandrina Estevez; Inam Kureshi; Jonathan L Brisman
Journal:  Stroke       Date:  2010-07-15       Impact factor: 7.914

7.  The rationale behind "A Randomized Trial of Unruptured Brain AVMs" (ARUBA).

Authors:  Christian Stapf
Journal:  Acta Neurochir Suppl       Date:  2010

Review 8.  Cerebral arteriovenous malformations: evaluation and management.

Authors:  Norman Ajiboye; Nohra Chalouhi; Robert M Starke; Mario Zanaty; Rodney Bell
Journal:  ScientificWorldJournal       Date:  2014-10-15

9.  Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients.

Authors:  Qingqing Ren; Min He; Yunhui Zeng; Zhiyong Liu; Hao Liu; Jianguo Xu
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

10.  External validation of brain arteriovenous malformation haemorrhage scores, AVICH, ICH and R2eD.

Authors:  Basel A Taweel; Conor S Gillespie; George E Richardson; Mohammad A Mustafa; Tamara Ali; Abdurrahman I Islim; Cathal J Hannan; Emmanuel Chavredakis
Journal:  Acta Neurochir (Wien)       Date:  2022-04-18       Impact factor: 2.816

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.